OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Discovery of a brain-permeable bromodomain and extra terminal domain (BET) inhibitor with selectivity for BD1 for the treatment of multiple sclerosis
Xuetao Chen, Tingting Wu, Zhiyan Du, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116080-116080
Closed Access | Times Cited: 7
Xuetao Chen, Tingting Wu, Zhiyan Du, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116080-116080
Closed Access | Times Cited: 7
Showing 7 citing articles:
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Binding Selectivity of Inhibitors to BRD2 Uncovered by Molecular Docking and Molecular Dynamics Simulations
Qian Bai, Ruige Wang, Shili Qin, et al.
Advanced Theory and Simulations (2025)
Closed Access
Qian Bai, Ruige Wang, Shili Qin, et al.
Advanced Theory and Simulations (2025)
Closed Access
Multi-Water Bridges Enable Design of BET BD1-Selective Inhibitors for Pancreatic Cancer Therapy
Xuetao Chen, Wenjing Kang, Tingting Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Xuetao Chen, Wenjing Kang, Tingting Wu, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Discovery of the First BRD4 Second Bromodomain (BD2)-Selective Inhibitors
Junhua Li, Qingqing Hu, Run Zhu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Junhua Li, Qingqing Hu, Run Zhu, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Synthesis and Characterization of New Bases Derived from Nitrophenylpyrazoles, Coordination to Palladium and Antifungal Activity and Catalytic Activity in Mizoroki–Heck Reactions
Jennifer Londoño-Salazar, Andrés Restrepo-Acevedo, John Eduard Torres, et al.
Catalysts (2024) Vol. 14, Iss. 6, pp. 387-387
Open Access | Times Cited: 2
Jennifer Londoño-Salazar, Andrés Restrepo-Acevedo, John Eduard Torres, et al.
Catalysts (2024) Vol. 14, Iss. 6, pp. 387-387
Open Access | Times Cited: 2
Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
Tingting Wu, Yali Chen, Qidong You, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116271-116271
Closed Access | Times Cited: 1
